Profile: CareFusion Corp (CFN.N)
21 Nov 2014
CareFusion Corporation (CareFusion), incorporated on January 14, 2009, is a global medical technology company. The Company’s offerings include established brands used in hospitals throughout the United States and approximately 130 countries worldwide. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company’s Medical Systems segment’s business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company’s disposable products and reusable surgical instruments businesses. The Company’s Procedural Solutions segment’s business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. On October 1, 2013, it completed the acquisition of Grupo Sendal, S.L (Sendal). Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.
The Company offers a portfolio of products in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care. Its primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment; and MedMined data mining surveillance software and analytics.
Medical Systems Segment
The Company’s develops, manufactures and markets capital equipment and related supplies for medication management, which includes its infusion and medication dispensing technologies, supply dispensing technologies and respiratory technologies. Its products are designed to enable healthcare professionals to improve patient safety by reducing medication errors and improving administrative controls, while simultaneously improving workflow and increasing operational efficiency. The Company sells these products primarily through its direct sales force, but use third-party distributors as well, particularly outside the United States. Many of its products in this segment are integrated with the Healthcare Information Technology (HCIT) systems within the hospital, allowing data integration and bi-directional information flow between its devices and its customers’ financial and business systems that support patient admissions, discharges and transfers, physician order entry, and other clinical and operational systems.
Many of its products in this segment are integrated with other information systems within the hospital, including financial and business systems that support patient admissions, discharges and transfers, operational systems that include inventory management and clinical systems that include pharmacy information and electronic medical records.
The Company offers value-added services and programs, software technical services and clinical education, which are designed to enhance its customers’ utilization of its medical equipment products. The Company’s project management, field service organization and customer call centers support its customers before, during and after product installation. The Company’s project management teams assist customers with the development of project implementation plans, which are designed to ensure rapid, seamless implementation of its products. The Company’s field service organization provides on-site expertise to resolve customers’ service issues. The Company’s customer call centers provide additional support to its customers.
The Company is engaged in designing, developing and marketing of IV infusion systems that deliver medications and other fluids directly into a patient’s veins in precise, measured quantities over a range of infusion rates. The Company is provider of point-of-care systems that automate the dispensing of medications and supplies in hospitals and other healthcare facilities in the United States. The Company develops, manufactures, markets and services mechanical ventilators and associated consumables for patients with respiratory disorders.
The Company competes with Baxter International, B. Braun, Fresenius Kabi, Hospira, Omnicell, McKesson; Drager, and MAQUET.
Procedural Solutions Segment
The Procedural Solutions segment is organized around its disposable products and reusable surgical instruments businesses. In its Procedural Solutions segment, the Company develops, manufactures and markets single-use skin antiseptic and other patient-preparation products, non-dedicated IV infusion administration sets and accessories, reusable surgical instruments and non-dedicated ventilator circuits and other disposables used for providing respiratory therapy. The products in this segment are used in the operating room, interventional suites, and in the critical care departments of hospitals. The Company sells these products and services through a combination of direct sales representatives and third-party distributors.
The Company’s Infection Prevention business unit consists mainly of single-use medical products used in surgical and vascular access procedures, including skin preparation products and disposable IV infusion administration sets and accessories. The Company’s Medical Specialties business unit consists mainly of specialty medical devices used in delivering interventional care and reusable surgical instrumentation products. The Company’s Specialty Disposables business unit focuses on providing clinicians with respiratory consumable products that work either independently or in conjunction with its range of ventilators.
The Company competes with 3M, ICU Medical, Becton, Dickinson, Baxter International, B. Braun; Hospira; Smiths Medical; CR Bard, Integra Life Sciences, and Teleflex.
3750 Torrey View Ct
SAN DIEGO CA 92130-2622
Company Web Links
- Goldman leads $9.1 billion bridge loan for Becton Dickinson
- RLPC-Goldman leads $9.1bn bridge loan for Becton Dickinson
- Becton Dickinson to buy CareFusion for $12 billion in cash, stock
- UPDATE 3-Becton Dickinson to buy CareFusion for $12 bln in cash, stock
- Becton Dickinson to buy CareFusion for $12 billion in cash, stock